ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,258Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 457

$2.92M Total Retail Price of All Prescriptions

Rank: 4 out of 457

762 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 762 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 28,958 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,307 1,126 1 1
CRESTOR 997 839 2 9
NEXIUM 916 784 3 12
TRICOR 704 593 10 4 83
LEVOTHYROXINE SODIUM 630 594 5 5
NAMENDA 625 612 6 32
AMLODIPINE BESYLATE 578 536 7 4
ESCITALOPRAM OXALATE 541 495 8 61
PRAVASTATIN SODIUM 527 471 9 29
DONEPEZIL HCL 502 485 10 22
VOLTAREN 498 434 11 34
ACTONEL 496 480 12 117
LISINOPRIL 479 426 13 3
MELOXICAM 447 412 14 41
METOPROLOL SUCCINATE 419 383 15 21
CLOPIDOGREL 416 383 16 19
ATORVASTATIN CALCIUM 410 355 17 33
PLAVIX 403 375 18 24
FENOFIBRATE 387 331 19 46
LYRICA 367 291 20 77
DIOVAN HCT 356 337 21 51
SIMVASTATIN 347 334 22 2
ATENOLOL 341 327 23 11
AVODART 338 321 24 110
JANUMET 321 268 25 154
TRAMADOL HCL 311 259 26 26
ZOLPIDEM TARTRATE 310 298 27 13
CARVEDILOL 307 273 28 20
EXELON 303 297 29 98
TAMSULOSIN HCL 297 276 30 36
BENICAR HCT 296 268 31 111
METFORMIN HCL 291 267 32 6
ADVAIR DISKUS 271 193 33 27
FAMOTIDINE 268 247 34 62
JANUVIA 267 256 35 80
BENICAR 255 229 36 90
LEXAPRO 249 223 37 138
ALENDRONATE SODIUM 249 244 37 16
FUROSEMIDE 247 212 39 10
IBUPROFEN 247 219 39 14
CLOTRIMAZOLE-BETAMETHASONE 242 232 41 60
SYNTHROID 241 203 42 93
SINGULAIR 239 192 43 43
CELEBREX 230 207 44 53
TEMAZEPAM 228 228 45 48
LOSARTAN POTASSIUM 225 187 46 18
SPIRONOLACTONE 218 203 47 124
METOPROLOL TARTRATE 216 198 48 7
PANTOPRAZOLE SODIUM 216 193 48 59
LOVAZA 207 200 50 50
HYDROCHLOROTHIAZIDE 206 182 51 8
RANITIDINE HCL 201 186 52 17
ALLOPURINOL 200 193 53 47
VYTORIN 195 184 54 234
MECLIZINE HCL 193 188 55 55
FLUTICASONE PROPIONATE 192 163 56 40
AZITHROMYCIN 190 157 57 44
KOMBIGLYZE XR 188 165 10 58 239
METFORMIN HCL ER 188 170 58 143
MONTELUKAST SODIUM 182 155 60 86
DIOVAN 171 162 61 30
FOLIC ACID 170 167 62 81
LOSARTAN-HYDROCHLOROTHIAZIDE 165 130 63 54
CLOBETASOL PROPIONATE 161 140 64 125
POTASSIUM CHLORIDE 161 145 64 28
ACTOS 159 150 66 105
CYMBALTA 159 137 66 97
METHOTREXATE 152 141 68 343
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 143 69 37
ZETIA 139 137 70 137
LIDODERM 138 111 71 31
GABAPENTIN 137 122 72 15
AMMONIUM LACTATE 133 115 73 82
CITALOPRAM HBR 133 128 73 45
DICYCLOMINE HCL 131 127 75 115
TORSEMIDE 127 109 76 278
LANSOPRAZOLE 125 122 77 74
LANTUS SOLOSTAR 123 93 78 121
DOXAZOSIN MESYLATE 119 119 79 73
CIPROFLOXACIN HCL 116 110 80 71
ABILIFY 110 96 81 146
NAPROXEN 109 90 82 65
ALPRAZOLAM 104 99 83 39
CLONAZEPAM 103 98 84 162
PREMARIN 100 76 R 85 253
IBANDRONATE SODIUM 100 86 85 183
SPIRIVA 99 79 87 101
PROAIR HFA 99 65 87 66
CLONIDINE HCL 99 93 87 52
ACTOPLUS MET 97 91 90 309
LEVOFLOXACIN 89 76 91 131
PEN NEEDLE 88 75 92 186
MUPIROCIN 85 66 93 91
LUNESTA 83 83 94 254
LEVEMIR FLEXPEN 81 81 95 243
TRAMADOL HCL-ACETAMINOPHEN 81 77 95 134
GLYBURIDE-METFORMIN HCL 79 71 R 97 70
BONIVA 75 74 98 206
EXFORGE 75 54 98 149
MEGESTROL ACETATE 74 74 R 100 94
CIALIS 74 61 100 119
CYCLOBENZAPRINE HCL 73 60 R 102 99
ISOSORBIDE MONONITRATE ER 72 72 103 84
DEXILANT 70 51 104 118
PIOGLITAZONE HCL 70 65 R 104 251
NASONEX 68 53 106 129
PROCTOZONE-HC 68 50 106 193
SERTRALINE HCL 63 51 108 57
DILTIAZEM 24HR CD 62 60 109 232
ENALAPRIL MALEATE 62 53 109 35
TEKTURNA 61 52 111 211
MICARDIS HCT 60 55 112 222
OLANZAPINE 59 59 113 201
AMLODIPINE BESYLATE-BENAZEPRIL 59 59 113 72
MOMETASONE FUROATE 58 31 115 267
DIGOXIN 58 57 115 69
DICLOFENAC SODIUM 57 51 117 49
TRIBENZOR 56 54 118 312
PAROXETINE HCL 56 52 118 68
WARFARIN SODIUM 56 44 118 38
CICLOPIROX 55 35 121 126
PREDNISONE 55 53 121 95
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 48 123 153
ATELVIA 53 52 124 247
QUETIAPINE FUMARATE 52 52 125 109
FLUCONAZOLE 52 48 125 255
VERAPAMIL ER 52 52 125 145
METRONIDAZOLE 51 46 128 319
METOCLOPRAMIDE HCL 51 49 128 116
FINASTERIDE 50 50 130 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.